BLNK
B-cell linker protein
Also known as: BASH, bca, BLNK_HUMAN, BLNK-s, Ly57, SLP-65, SLP65
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WV28
- Gene
- BLNK
- Ensembl
- ENSG00000095585
- Chromosome
- 10
- Canonical length
- 456 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane
OverviewNCBI Gene
This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]
Canonical amino-acid sequenceUniProt
456 residues, UniProt reviewed canonical sequence.
>Q8WV28|BLNK
1 MDKLNKITVP ASQKLRQLQK MVHDIKNNEG GIMNKIKKLK VKAPPSVPRR DYASESPADE
61 EEQWSDDFDS DYENPDEHSD SEMYVMPAEE NADDSYEPPP VEQETRPVHP ALPFARGEYI
121 DNRSSQRHSP PFSKTLPSKP SWPSEKARLT STLPALTALQ KPQVPPKPKG LLEDEADYVV
181 PVEDNDENYI HPTESSSPPP EKAPMVNRST KPNSSTPASP PGTASGRNSG AWETKSPPPA
241 APSPLPRAGK KPTTPLKTTP VASQQNASSV CEEKPIPAER HRGSSHRQEA VQSPVFPPAQ
301 KQIHQKPIPL PRFTEGGNPT VDGPLPSFSS NSTISEQEAG VLCKPWYAGA CDRKSAEEAL
361 HRSNKDGSFL IRKSSGHDSK QPYTLVVFFN KRVYNIPVRF IEATKQYALG RKKNGEEYFG
421 SVAEIIRNHQ HSPLVLIDSQ NNTKDSTRLK YAVKVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BLNK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- spleen: 53 nTPM
- tonsil: 42 nTPM
- esophagus: 39 nTPM
- liver: 38 nTPM
- lymph node: 33 nTPM
- small intestine: 26 nTPM
Single-cell type
- microglia: 703 nCPM
- esophageal apical cells: 671 nCPM
- pdcs: 330 nCPM
- distal convoluted tubule cells: 302 nCPM
- renal connecting tubule cells: 261 nCPM
- ocular epithelial cells: 249 nCPM
Immune cell
- plasmacytoid DC: 159 nTPM
- memory B-cell: 111 nTPM
- naive B-cell: 95 nTPM
- myeloid DC: 13 nTPM
- total PBMC: 5.5 nTPM
- NK-cell: 1.6 nTPM
Brain region
- choroid plexus: 34 nTPM
- thalamus: 21 nTPM
- hypothalamus: 21 nTPM
- medulla oblongata: 21 nTPM
- white matter: 21 nTPM
- pons: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BLNK.
Disease | AllUniProt
Conditions BLNK is implicated in, by any mechanism.
- Agammaglobulinemia 4, autosomal recessive (AGM4) MIM:613502
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 409 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Agammaglobulinemia 4, autosomal recessive
- BLNK-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.61
- gnomAD missense Z
- 1.5
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- B cell receptor signaling pathway
- cell surface receptor protein tyrosine kinase signaling pathway
- humoral immune response
- inflammatory response
- intracellular signal transduction
- positive regulation of gene expression
Molecular functions
- enzyme binding
- lipid binding
- molecular condensate scaffold activity
- phospholipase binding
- protein kinase binding
- protein tyrosine kinase binding
- SH2 domain binding
- signaling adaptor activity
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BLNK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BLNK as an antibody target. Whether an autoantibody or antibody against BLNK could matter depends on whether native BLNK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BLNK is annotated at the cell surface, where native BLNK is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BLNK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...